Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors.
Ni, Yike; Gopalsamy, Ariamala; Cole, Derek; Hu, Yonghan; Denny, Rajiah; Ipek, Manus; Liu, Julie; Lee, Julie; Hall, J Perry; Luong, Michael; Telliez, Jean-Baptiste; Lin, Lih-Ling.
Bioorg Med Chem Lett
; 21(19): 5952-6, 2011 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-21862328
Structure-guided development of covalent TAK1 inhibitors.
Assaying kinase activity of the TPL-2/NF-κB1 p105/ABIN-2 complex using an optimal peptide substrate.
Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
GSK114: A selective inhibitor for elucidating the biological role of TNNI3K.
Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD).
TAK1 is involved in the autophagy process in retinal pigment epithelial cells.
Identification of a selective inhibitor of transforming growth factor ß-activated kinase 1 by biosensor-based screening of focused libraries.
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.
Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors.
A Potassium-Dependent Oxygen Sensing Pathway Regulates Plant Root Hydraulics.